We are live on ! Find out more
2L

22NW LP Portfolio holdings

AUM $146M
1-Year Est. Return 29.83%
This Fund
S&P 500
This Quarter Est. Return
+15.61%
1 Year Est. Return
+29.83%
3 Year Est. Return
+131.37%
5 Year Est. Return
+199.25%
10 Year Est. Return
AUM
$159M
AUM Growth
+$39.2M
Cap. Flow
+$23.4M
Cap. Flow %
14.79%
Top 10 Hldgs %
93.11%
Holding
16
New
3
Increased
2
Reduced
Closed

Top Buys

Rank Stock Value
1
ANEB
Anebulo Pharmaceuticals
ANEB
+$16.6M
2
SRI icon
Stoneridge
SRI
+$2.63M
3
NKTR icon
Nektar Therapeutics
NKTR
+$2.58M
4
UFI icon
UNIFI
UFI
+$1.43M
5
CULP icon
Culp Inc
CULP
+$166K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Industrials 42.19%
2 Healthcare 40.65%
3 Consumer Discretionary 8.29%
4 Financials 3.74%
5 Technology 2.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FSTR icon
1
Foster
FSTR
$443M
$35.3M 22.28%
1,313,121
LFCR icon
2
Lifecore Biomedical
LFCR
$162M
$31.1M 19.65%
1,755,161
ANEB
3
DELISTED
Anebulo Pharmaceuticals
ANEB
$26M 16.39%
15,467,300
+10,101,010
+188% +$16.6M
STRL icon
4
Sterling Infrastructure
STRL
$20.3B
$16.8M 10.6%
99,783
BBSI icon
5
Barrett Business Services
BBSI
$976M
$11.5M 7.26%
264,904
CULP icon
6
Culp Inc
CULP
$45M
$9.54M 6.02%
1,624,715
+30,325
+2% +$166K
PFX icon
7
PhenixFIN
PFX
$83.9M
$5.92M 3.74%
117,885
DHX icon
8
DHI Group
DHX
$166M
$4.61M 2.91%
2,603,643
FARM
9
DELISTED
Farmer Brothers
FARM
$3.52M 2.22%
1,955,526
MTW icon
10
Manitowoc
MTW
$516M
$3.25M 2.05%
356,115
LNTH icon
11
Lantheus
LNTH
$6.82B
$3.09M 1.95%
34,562
SRI icon
12
Stoneridge
SRI
$209M
$2.15M 1.36%
+342,787
New +$2.63M
NKTR icon
13
Nektar Therapeutics
NKTR
$2.39B
$2.04M 1.29%
+146,117
New +$2.58M
SSKN
14
DELISTED
Strata Skin Sciences
SSKN
$1.56M 0.98%
536,995
UFI icon
15
UNIFI
UFI
$117M
$1.46M 0.92%
+233,777
New +$1.43M
PMD
16
DELISTED
Psychemedics Corporation
PMD
$618K 0.39%
276,034

Similar funds

22NW LP's Q4 2024 Portfolio in Review

As of Q4 2024, 22NW LP held 16 positions worth $159M, up 33% from $119M the previous quarter. Its ten largest holdings account for 93% of the portfolio.

22NW LP deployed $23.4M of net new capital in Q4 2024, opening 3 new positions and adding to 2 existing holdings. Its largest new stake was Stoneridge: 342,787 shares worth $2.15M.

By sector, the portfolio is most concentrated in Industrials at 42% of assets, down from 46% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • 22NW LP's largest Q4 2024 buy was Stoneridge: 342,787 shares worth $2.15M.
  • 22NW LP added most to Anebulo Pharmaceuticals in Q4 2024, an estimated $16.6M increase.
  • 22NW LP's ten largest holdings make up 93% of its $159M portfolio in Q4 2024.
  • 22NW LP opened 3 new positions and closed 0 in Q4 2024.
  • 22NW LP's portfolio value rose 33% quarter-over-quarter to $159M.

Based on 22NW LP's 13F filing for Q4 2024, filed 14 Feb 2025.